HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$2.61
Day range
$2.51 - $2.72
Year range
$1.05 - $8.00
Market cap
79.83M USD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.69M | -21.69% |
Net income | -18.23M | 18.75% |
Net profit margin | — | — |
Earnings per share | -0.47 | 20.34% |
EBITDA | -19.34M | 22.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 129.25M | -31.05% |
Total assets | 145.30M | -32.32% |
Total liabilities | 16.70M | -6.16% |
Total equity | 128.60M | — |
Shares outstanding | 31.56M | — |
Price to book | 0.64 | — |
Return on assets | -32.39% | — |
Return on capital | -35.42% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -18.23M | 18.75% |
Cash from operations | -12.28M | 29.09% |
Cash from investing | 5.91M | -63.08% |
Cash from financing | -117.00K | 92.22% |
Net change in cash | -6.49M | -130.43% |
Free cash flow | -7.64M | 15.30% |
About
Founded
2018
Headquarters
Website
Employees
77
